| |
| |
|
| Insider
Information: |
Kendall Keith J |
| Relationship: |
|
| City: |
Warren |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
639,149 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,859,924 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
639,149 |
|
|
| Total
Value |
$1,859,924 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aquestive Therapeutics, Inc. |
AQST |
|
2020-06-30 |
639,149 |
2018-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-06-30 |
4 |
D |
$4.86 |
$719 |
D/D |
(148) |
639,149 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
639,297 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-06-04 |
4 |
AS |
$5.11 |
$255,310 |
D/D |
(50,000) |
638,964 |
0 |
% |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-05-31 |
4 |
D |
$4.87 |
$31,616 |
D/D |
(6,492) |
688,964 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,572 |
695,456 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
680,983 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-03-31 |
4 |
D |
$2.19 |
$217 |
D/D |
(99) |
680,884 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-02-29 |
4 |
D |
$3.73 |
$17,639 |
D/D |
(4,729) |
680,654 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2020-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,572 |
685,383 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-12-31 |
4/A |
D |
$5.82 |
$867 |
D/D |
(149) |
670,811 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-12-31 |
4 |
D |
$5.82 |
$1,915 |
D/D |
(329) |
662,656 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
662,985 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,572 |
677,228 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-11-30 |
4 |
D |
$7.79 |
$113,516 |
D/D |
(14,572) |
662,656 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-11-30 |
4/A |
D |
$7.79 |
$51,391 |
D/D |
(6,597) |
670,631 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-09-30 |
4 |
D |
$3.18 |
$477 |
D/D |
(150) |
662,656 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
662,806 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-08-31 |
4 |
D |
$3.80 |
$25,369 |
D/D |
(6,676) |
662,477 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,572 |
669,153 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-08-14 |
4 |
B |
$3.65 |
$7,347 |
D/D |
2,000 |
654,581 |
0.01 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-08-13 |
4 |
B |
$4.05 |
$4,045 |
D/D |
1,000 |
652,581 |
0.01 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-08-09 |
4 |
B |
$3.84 |
$19,595 |
D/D |
5,000 |
651,581 |
0.01 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-06-30 |
4 |
D |
$4.20 |
$647 |
D/D |
(154) |
646,581 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
646,735 |
0 |
- |
|
| AQST |
Aquestive Therapeutics, I... |
CEO and President |
• • – |
2019-05-31 |
4 |
D |
$3.72 |
$25,222 |
D/D |
(6,780) |
646,406 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
